Side effects, allergies, interactions and duplications

Why Drug Utilization Review Matters

Every time a prescription is processed, the dispensing software runs a drug utilization review (DUR). This automated check compares the new prescription against the patient's profile and flags anything that could harm them. As a pharmacy technician, you will see these alerts constantly. Your job is not to resolve them — it is to recognize what each alert means and route every one to the pharmacist immediately. The pharmacist is the licensed professional who decides whether to dispense, contact the prescriber, or counsel the patient.

Adverse Effects and Side Effects

A side effect is an unwanted but predictable response to a drug at a normal dose. Side effects are not errors — they are known properties of the medication. For example, opioid analgesics such as oxycodone routinely cause constipation, and metformin commonly causes nausea when first started. Knowing common side effects helps you understand why a patient profile might show a laxative alongside an opioid, or why the software may generate a note about GI disturbance.

An adverse drug reaction (ADR) is a broader term covering any harmful, unintended response to a medication at a normal dose. ADRs range from mild (drowsiness from diphenhydramine) to severe (QT-interval prolongation from certain antibiotics). When an ADR is serious or unexpected, it must be documented and, under USP and FDA MedWatch guidelines, reported through the appropriate channel — always a pharmacist-level responsibility.

Allergies and Contraindications

A drug allergy is an immune-mediated reaction. The classic example is penicillin, which can trigger anything from a mild rash to life-threatening anaphylaxis. The DUR system stores allergy information and alerts when a new drug belongs to the same class or shares a chemical structure with a documented allergen — this is called a cross-sensitivity alert. For instance, a documented penicillin allergy may trigger an alert when a cephalosporin is prescribed because of structural similarities between the two drug classes.

A contraindication means the drug should not be used because the risk clearly outweighs any benefit. Contraindications may be absolute (never use) or relative (use with extreme caution and monitoring). A drug–disease contraindication is one of the most common alert types: for example, non-selective beta-blockers are contraindicated in patients with asthma because they can cause severe bronchospasm. Any allergy alert or contraindication flag must go directly to the pharmacist — a technician never overrides these.

Drug–Drug Interactions

A drug–drug interaction (DDI) occurs when one drug alters the effect of another. Interactions fall into two main categories:

• Pharmacokinetic interactions affect how the body handles a drug — absorption, distribution, metabolism, or elimination. The cytochrome P450 (CYP450) enzyme system in the liver is central to many of these. A CYP inhibitor (such as fluconazole) slows the breakdown of other drugs metabolized by that enzyme, raising their blood levels and risk of toxicity. A CYP inducer (such as rifampin) speeds up metabolism, lowering blood levels and potentially causing treatment failure.

• Pharmacodynamic interactions occur when two drugs affect the same body system, multiplying or opposing each other's effects. Taking two CNS depressants together — such as a benzodiazepine and an opioid — can dangerously increase sedation and respiratory depression. This combination carries an FDA black-box warning.

Severity levels assigned by most DUR systems range from minor to contraindicated. Even a moderate-severity DDI alert must be passed to the pharmacist, who will assess the clinical context.

Drug–Disease Interactions

A drug–disease interaction occurs when a medication worsens an existing medical condition. Common examples include:

• NSAIDs (such as ibuprofen) used in patients with chronic kidney disease — NSAIDs reduce renal blood flow and can accelerate kidney damage.
• Oral decongestants such as pseudoephedrine used in patients with hypertension — they raise blood pressure.
• Anticholinergic medications used in patients with benign prostatic hyperplasia — they can cause urinary retention.

The patient's diagnosis list or problem list stored in the pharmacy software enables the DUR system to flag these situations.

Therapeutic Duplication

Therapeutic duplication (also called duplicate therapy) occurs when a patient has two or more drugs from the same therapeutic class or with the same mechanism of action prescribed at the same time, often by different prescribers. This is different from an intentional combination. Examples include two statin medications on the same profile, or two ACE inhibitors dispensed from different pharmacies. Duplication increases the risk of additive toxicity without added benefit and often signals a communication gap between providers. When the DUR software flags a duplication, the pharmacist must review it before dispensing continues.

Your Role in the DUR Process

As a technician, your responsibility in DUR is clear and consistent:

1. Never dismiss or override an alert on your own. Even an alert that seems minor must be seen by the pharmacist.

2. Communicate the alert clearly. State the patient's name, the drug involved, and the type of alert (interaction, allergy, duplication, contraindication).

3. Document as directed. Some software systems require the technician to log that the alert was flagged before the pharmacist can review it.

4. Protect patient confidentiality throughout the process — all alert information is protected health information under HIPAA.

The pharmacy team functions as a safety net. Recognizing these alert categories and immediately involving the pharmacist keeps that net intact.